Seems like every woman in today's culture longs for a curvy figure complete with an ample, full bust line. Let's face it, cleavage and curves are sexy and attractive. For years, women have been trying various methods to increase their bust line measurement. Creams, exercises, injections, and implants have been tried over the decades, some with more success than others.
There has been recent advancement in the field of breast augmentation using a method involving stem cells. Stem cells are taken from a woman's fatty areas in her abdomen and thighs. They are then injected into the breasts which, after several months, have grown by at least one bra cup size.
Studies have proven successful in trials of women who have lost breast tissue due to cancer. This option is now apparently moving into the realm of cosmetic rather than reconstructive augmentation.
Traditional breast augmentation involves surgically implanting a medical device called an implant into the woman's breast. The implants are either filled with silicone or filled with a saline solution which is similar to the salty water consistency found naturally in a human body.
Incisions are made in scar hiding areas such as the armpit, underneath the drooping portion or beneath the areola area. The downside to the implants is that they may rupture or not feel as soft and natural as non-implanted tissue.
With stem cell augmentation, the result is said to be very soft and natural feeling. The downside is that while the amount of tissue is increased, it will not be tightened up or uplifted, if that is something that is necessary.
Stem cell injections are different from fat transfers. Fat transfers involve moving adipose tissue from one area to the other. Often the fat will die and be reabsorbed by the body, but the stem cells will grow new tissue over a period of months. The rejection rate for the new procedure is reportedly lower.
This method remains controversial in the United States. It has been performed with success in both Japan and Great Britain, but the U.S. has hurdles to clear regarding the regulation by the Food and Drug Administration. The FDA is the governmental agency that oversees the safety of medical devices and drugs, among other things. Transferring items such as stem cells from one's own body is a tricky procedure in terms of classification and the legalities of overseeing.
If you're still waiting for the perfect new way to augment your breasts, this may be the one for you.
Monday, October 26, 2009
Leukemia For Twins and Stem Cells Solutions
Although there are no accurate data for concordance rates of leukemia in infant twins, anecdotally it seems to be exceptionally high, perhaps approaching one hundred percent that is, if one twin has it, unfortunately so will the other. If correct, this suggests that MLL gene fusion in utero has a dramatic impact, ensuring subsequent leukemia. But for children aged two to six years with acute lymphoblastic leukemia, the concordance rate is considerably lower at around five percent. This still represents a one hundred fold extra risk of leukemia for the twin of a patient with acute lymphoblastic leukemia but also indicates the need for some additional postnatal event for which there is a one in twenty chance, or ninety five percent discordance. This suggests, at a minimum, a "two hit" model for the natural course of childhood leukemia.
If this model of leukemia development is correct, then, for every child with acute lymphoblastic leukemia diagnosed, there should be at least twenty healthy children who have had a chromosome translocation, a functional leukemia fusion gene, and a covert preleukaemic clone generated in utero. This possibility has been investigated by screening unselected samples of newborn cord blood for fusion genes. About six hundred samples have been screened, and around one percent have a leukemia TELAML1 fusion gene. This one percent represents a hundred times the cumulative rate or risk of acute lymphoblastic leukemia, indicating that the frequency of conversion of the preleukaemic clone to overt disease is low. The real bottleneck in development of acute lymphoblastic leukemia therefore seems to be a stringent requirement for a second "hit" after birth-that is, exposure and additional chromosomal or molecular abnormality.
A key issue to resolve is what exposures or events might precipitate the chromosome breaks whose improper repair initiates or promotes childhood leukemia. Given the biological diversity of leukemia, it is highly unlikely that there is a single cause. Even for a defined biological subtype of the disease, there probably is not one cause as such but a causal mechanism. As with other cancers, this is likely to involve an interaction of exposure, exogenous or endogenous, with inherent genetic susceptibility, and chance. Epidemiological evidence suggests that ionizing radiation; certain chemicals such as benzene, viruses, and bacteria may play a part in the development of some subtypes of leukemia and lymphoma in adults and children.
Whether any of these exposures have a major role in childhood leukemia is uncertain, but large scale case control molecular epidemiological studies in Britain and the United States may provide answers. The United Kingdom children's cancer study (UKCCS) seeks to address several hypotheses on different exposures, combined with definition of biological subtypes of disease and genetic studies. It and a parallel US study have already ruled out electromagnetic fields as a major factor in leukemia aetiology.
Having stem cells extracted from the cord blood at birth and stored in a cord blood bank or a stem cells bank is a way to protect your child from future diseases.
It can be very useful as it contains hematopoietic stem cells, progenitor cells. The stem cells in the cord blood are mainly used to treat blood and immune system related genetic diseases, cancers and blood disorders like diabetes or leukamia.
If this model of leukemia development is correct, then, for every child with acute lymphoblastic leukemia diagnosed, there should be at least twenty healthy children who have had a chromosome translocation, a functional leukemia fusion gene, and a covert preleukaemic clone generated in utero. This possibility has been investigated by screening unselected samples of newborn cord blood for fusion genes. About six hundred samples have been screened, and around one percent have a leukemia TELAML1 fusion gene. This one percent represents a hundred times the cumulative rate or risk of acute lymphoblastic leukemia, indicating that the frequency of conversion of the preleukaemic clone to overt disease is low. The real bottleneck in development of acute lymphoblastic leukemia therefore seems to be a stringent requirement for a second "hit" after birth-that is, exposure and additional chromosomal or molecular abnormality.
A key issue to resolve is what exposures or events might precipitate the chromosome breaks whose improper repair initiates or promotes childhood leukemia. Given the biological diversity of leukemia, it is highly unlikely that there is a single cause. Even for a defined biological subtype of the disease, there probably is not one cause as such but a causal mechanism. As with other cancers, this is likely to involve an interaction of exposure, exogenous or endogenous, with inherent genetic susceptibility, and chance. Epidemiological evidence suggests that ionizing radiation; certain chemicals such as benzene, viruses, and bacteria may play a part in the development of some subtypes of leukemia and lymphoma in adults and children.
Whether any of these exposures have a major role in childhood leukemia is uncertain, but large scale case control molecular epidemiological studies in Britain and the United States may provide answers. The United Kingdom children's cancer study (UKCCS) seeks to address several hypotheses on different exposures, combined with definition of biological subtypes of disease and genetic studies. It and a parallel US study have already ruled out electromagnetic fields as a major factor in leukemia aetiology.
Having stem cells extracted from the cord blood at birth and stored in a cord blood bank or a stem cells bank is a way to protect your child from future diseases.
It can be very useful as it contains hematopoietic stem cells, progenitor cells. The stem cells in the cord blood are mainly used to treat blood and immune system related genetic diseases, cancers and blood disorders like diabetes or leukamia.
Actual Embryonic Stem Cells Derived Without Killing the Embryos
When you receive the Seal you will understand the value of human life. Now (Jan 12 2008) human embryo stem cells have been produced from embryos without destroying the embryos.
In the last few months of 2007 there were breakthroughs in producing cells that were very much like human embryo stem cells (hESC) from ordinary skin cells. That was a tremendous breakthrough itself.
But hESC is still considered the "gold standard" for research and is still considered highly valuable and even necessary for research. Now thanks to this new research, it is possible to create hESC without killing embryos.
In 2006 a study showed that hESC could be derived from a single blastomere. A blastomere is the kind of cell created by the embryo in the very first week following fertilization when the embryo begins to divide.
But in that first study in 2006, many cells were taken out of each embryo so that they could not develop anymore. In this study, researchers derived five hESC lines without destroying the embryos, including one without co-culture.
Co-culture is the growth of distinct cell types in a combined culture. This meant that stem cells were needed from other embryos that ended up being destroyed. Co-culture is not a necessary part of this new procedure.
In this procedure, single blastomeres were taken out of the embryos using a process similar to preimplantation genetic diagnosis (PGD.) PGD is a procedure whereby embryos are made free of disease before implantation.
The "biopsied" embryos were further grown until they became blastocysts and then were frozen (instead of killed.) A biopsy is the removal of cells from the embryo, and the blastocyst stage is right after the zygote stage and before the embryo is known as an "embryo."
The blastomeres were cultured with a technique that was comparable in efficiency to "whole embryo derivations" which destroy the embryos. This is important--the high level of efficiency makes it a viable procedure.
And the derived stem cell lines had the same kind of pluripotency as whole embryo derivations. Pluripotency is the ability of the stem cell to become a cell of any of the three germ layers--ectoderm, mesoderm, and endoderm.
The White House still needs to approve this new technique as a way to get stem cells without destroying the embryos. But this is a major advancement in science--a step forward for the sanctity of life.
This is a solution to the ethical problem of stem-cell research, since embryos can now "share" their life-giving cells with researchers who desperately need them, and still grow up to be healthy adults.
When you are sealed you will begin to understand the sanctity of life. You will understand how God gave Life to people in the beginning and continues to give Life to them.
Of course, the greater kind of life is spiritual Life. The life in this world is a gift from God but the spiritual Life for eternity in Heaven is the ultimate gift and much better than the short and miserable opportunity in this world.
When you are sealed God will give you new life. He will give you a second chance. And He will give you the chance to live forever with Him in Heaven when you receive the Seal.
In the last few months of 2007 there were breakthroughs in producing cells that were very much like human embryo stem cells (hESC) from ordinary skin cells. That was a tremendous breakthrough itself.
But hESC is still considered the "gold standard" for research and is still considered highly valuable and even necessary for research. Now thanks to this new research, it is possible to create hESC without killing embryos.
In 2006 a study showed that hESC could be derived from a single blastomere. A blastomere is the kind of cell created by the embryo in the very first week following fertilization when the embryo begins to divide.
But in that first study in 2006, many cells were taken out of each embryo so that they could not develop anymore. In this study, researchers derived five hESC lines without destroying the embryos, including one without co-culture.
Co-culture is the growth of distinct cell types in a combined culture. This meant that stem cells were needed from other embryos that ended up being destroyed. Co-culture is not a necessary part of this new procedure.
In this procedure, single blastomeres were taken out of the embryos using a process similar to preimplantation genetic diagnosis (PGD.) PGD is a procedure whereby embryos are made free of disease before implantation.
The "biopsied" embryos were further grown until they became blastocysts and then were frozen (instead of killed.) A biopsy is the removal of cells from the embryo, and the blastocyst stage is right after the zygote stage and before the embryo is known as an "embryo."
The blastomeres were cultured with a technique that was comparable in efficiency to "whole embryo derivations" which destroy the embryos. This is important--the high level of efficiency makes it a viable procedure.
And the derived stem cell lines had the same kind of pluripotency as whole embryo derivations. Pluripotency is the ability of the stem cell to become a cell of any of the three germ layers--ectoderm, mesoderm, and endoderm.
The White House still needs to approve this new technique as a way to get stem cells without destroying the embryos. But this is a major advancement in science--a step forward for the sanctity of life.
This is a solution to the ethical problem of stem-cell research, since embryos can now "share" their life-giving cells with researchers who desperately need them, and still grow up to be healthy adults.
When you are sealed you will begin to understand the sanctity of life. You will understand how God gave Life to people in the beginning and continues to give Life to them.
Of course, the greater kind of life is spiritual Life. The life in this world is a gift from God but the spiritual Life for eternity in Heaven is the ultimate gift and much better than the short and miserable opportunity in this world.
When you are sealed God will give you new life. He will give you a second chance. And He will give you the chance to live forever with Him in Heaven when you receive the Seal.
Stem Cell Enhancers For Healthy Stem Cells
Stem Cell Enhancers are a natural botanical extract that assists your body by maintaining healthy stem cell physiology. It is the first of it's kind of the latest phytoceutical product category "stem cell enhancers." Stem Enhancers are a blend of two compounds extracted from cyanophyta Aphanizomenon flos-aquae (AFA). The first extract contains an L-selectin ligand, which supports the release of stem cells (CD34 cells) from bone marrow. The secondary extract, a polysaccharide-rich fraction named Migratose, contributes to the migration of stem cells out of the blood and into the tissue.
Stem Cell Enhancers aid in the release of stem cells from the bone marrow into the bloodstream. This is beneficial to the body because stem cells are able to travel through the bloodstream to areas of the body where they are most crucial. Stem Cell Enhancers acts to support optimal organ and tissue function. As the body ages, numbers and quality of stem cells gradually decrease which makes the body more vulnerable to injury and other deleterious health issues. The benefits of healthy stem cell support can combat the effects of aging by making one feel stronger and more vigorous. Adult stem cells are found in bone marrow. Stem cells replace ailing or dysfunctional cells which is imperative to maintaining optimal health.
The effectiveness of Stem Cell Enhancers was established in a triple blind study. First, blood samples were taken, then volunteers were given Stem Enhance or a placebo. Another blood sample was then taken at 30, 60 and 120 minutes after ingestion of the consumables. Using Fluorescence-Activated Cell Sorting (FACS) it was determined that the consumption of Stem Enhance illicited a 25-30% increase in the number of circulating stem cells.
The benefits of healthy stem cell support includes enhancing optimal wellness and can fight effects of aging. Healthy stem cells can help you feel stronger and more vigorous as you advance into retirement years.
Let's face it, people today regardless of their age want to enjoy good health, fell and look better, and be able to do more play and hard work without tiring out to fast.
Stem Enhance is the all natural supplement that helps support the natural release of adult stem cells.
Stem Cell Enhancers aid in the release of stem cells from the bone marrow into the bloodstream. This is beneficial to the body because stem cells are able to travel through the bloodstream to areas of the body where they are most crucial. Stem Cell Enhancers acts to support optimal organ and tissue function. As the body ages, numbers and quality of stem cells gradually decrease which makes the body more vulnerable to injury and other deleterious health issues. The benefits of healthy stem cell support can combat the effects of aging by making one feel stronger and more vigorous. Adult stem cells are found in bone marrow. Stem cells replace ailing or dysfunctional cells which is imperative to maintaining optimal health.
The effectiveness of Stem Cell Enhancers was established in a triple blind study. First, blood samples were taken, then volunteers were given Stem Enhance or a placebo. Another blood sample was then taken at 30, 60 and 120 minutes after ingestion of the consumables. Using Fluorescence-Activated Cell Sorting (FACS) it was determined that the consumption of Stem Enhance illicited a 25-30% increase in the number of circulating stem cells.
The benefits of healthy stem cell support includes enhancing optimal wellness and can fight effects of aging. Healthy stem cells can help you feel stronger and more vigorous as you advance into retirement years.
Let's face it, people today regardless of their age want to enjoy good health, fell and look better, and be able to do more play and hard work without tiring out to fast.
Stem Enhance is the all natural supplement that helps support the natural release of adult stem cells.
How Can Stem Cell Research Be Used to Treat Congestive Heart Failure?
The potential needs for stem cells have made it a highly available focus in medical articles today. Stem cells are the precursors to all cell in the human body, and are primarily produced in the bone marrow in adults. During times of crisis, such as when a patient suffers from leukemia, the spleen and other organs that contain stem cells during infant development will take over production. This is the body's way of preserve proper cell balances and replenishing itself as old cells die. For example, red blood cells in the circulation merely have a lifespan of approximately four months; during that time the hematopoietic stem cell in the bone marrow are continuously producing new rubriblasts, the precursor cells that will over time become mature erythrocytes.
Heart failure is a devastating blow to the human body system, and despite the best efforts of major hospitals and researchers often results in permanent organ damage and eventual death. Researchers are fighting to put a stop to the high mortality rate of congestive heart failure, and believe stem cells may be the way to do it.
There are many forms of stem cells; for the sake of following a line of investigation scientists they are currently focusing on the embryonic and adult varieties. Embryonic stem cells come from a blastocyst, a four to five day old human embryo. During gestation these pluripotent cells will displace and breed, forming the human body and internal organs of the fetus. Embryonic stem cell are highly valued for inquiries for some reasons; they are able to provide large numbers of replenishing cells and have no limitations on what form of cells they can become. The use of embryonic stem cells is highly polemical, however, due to the fact that collection often requires the destruction of the embryo.
Stems cells may also can be grown for the purpose of transplants.Ts to be had for an organ transplant are not as easily obtained as physicians would wish for, and there are often waiting lists years long for every available organ. Stem cells grow readily in a laboratory nature, and if unstimulated to differentiate will imitate pluripotent daughter cells. This results in a tissue that will in effect adapt to whatever environment it is placed in. Research scientists theorize that with the proper environment essentially grow heart tissue and transplant it to the patient who has suffered signs and symptoms of congestive heart failure, replacing the dead and damaged tissues with live, vital tissue. This procedure would allow the heart to function more easily and hopefully give the patient a better chance for survival.
There are respective methods that have been published in research journals regarding the application of stem cells in the remedy of signs and symptoms of congestive heart failure failure. Congestive heart failure results when cells in the heart are dysfunctional or destroyed and the heart is unable to properly pump blood all the way through the body. Several patients are able to be treated using mechanical aids or transfer, but this is not each time the case. Several years ago a assemblage of patients with no other to be had options for treatment agreed to be part of a test analyze regarding stem cells. Autologous stem cells were taken out from the marrow and injected into the failing heart tissue through the chest wall. Patients who acknowledged this treatment showed clear progress, presumptively as a outcome of stem cell action. The microscopic means by which this occurs is still unknown; however, research scientists anticipate that the stem cell is either growing new vessels or acting as a beacon to bring other cells in to repair the damaged tissue.
With current medicine the prognosis for sufferers of congestive heart failure is grim. At least fifty percent will die within five years of being diagnosed, and individuals who are not victims of this mortality rate will feel the effects of their heart failure for the rest of their lives. Stem cell research represents at least a chance for those patients to beat these odds. With anything that is good there is also evil but in my humble opinion after much research I feel that stem cell research should continue.
Heart failure is a devastating blow to the human body system, and despite the best efforts of major hospitals and researchers often results in permanent organ damage and eventual death. Researchers are fighting to put a stop to the high mortality rate of congestive heart failure, and believe stem cells may be the way to do it.
There are many forms of stem cells; for the sake of following a line of investigation scientists they are currently focusing on the embryonic and adult varieties. Embryonic stem cells come from a blastocyst, a four to five day old human embryo. During gestation these pluripotent cells will displace and breed, forming the human body and internal organs of the fetus. Embryonic stem cell are highly valued for inquiries for some reasons; they are able to provide large numbers of replenishing cells and have no limitations on what form of cells they can become. The use of embryonic stem cells is highly polemical, however, due to the fact that collection often requires the destruction of the embryo.
Stems cells may also can be grown for the purpose of transplants.Ts to be had for an organ transplant are not as easily obtained as physicians would wish for, and there are often waiting lists years long for every available organ. Stem cells grow readily in a laboratory nature, and if unstimulated to differentiate will imitate pluripotent daughter cells. This results in a tissue that will in effect adapt to whatever environment it is placed in. Research scientists theorize that with the proper environment essentially grow heart tissue and transplant it to the patient who has suffered signs and symptoms of congestive heart failure, replacing the dead and damaged tissues with live, vital tissue. This procedure would allow the heart to function more easily and hopefully give the patient a better chance for survival.
There are respective methods that have been published in research journals regarding the application of stem cells in the remedy of signs and symptoms of congestive heart failure failure. Congestive heart failure results when cells in the heart are dysfunctional or destroyed and the heart is unable to properly pump blood all the way through the body. Several patients are able to be treated using mechanical aids or transfer, but this is not each time the case. Several years ago a assemblage of patients with no other to be had options for treatment agreed to be part of a test analyze regarding stem cells. Autologous stem cells were taken out from the marrow and injected into the failing heart tissue through the chest wall. Patients who acknowledged this treatment showed clear progress, presumptively as a outcome of stem cell action. The microscopic means by which this occurs is still unknown; however, research scientists anticipate that the stem cell is either growing new vessels or acting as a beacon to bring other cells in to repair the damaged tissue.
With current medicine the prognosis for sufferers of congestive heart failure is grim. At least fifty percent will die within five years of being diagnosed, and individuals who are not victims of this mortality rate will feel the effects of their heart failure for the rest of their lives. Stem cell research represents at least a chance for those patients to beat these odds. With anything that is good there is also evil but in my humble opinion after much research I feel that stem cell research should continue.
Subscribe to:
Comments (Atom)